Sildalis: A Comprehensive Dual-Action Therapy for Erectile Dysfunction
| Product dosage: 120mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 10 | $4.30 | $43.00 (0%) | 🛒 Add to cart |
| 20 | $2.58 | $86.00 $51.60 (40%) | 🛒 Add to cart |
| 30 | $2.29 | $129.00 $68.80 (47%) | 🛒 Add to cart |
| 60 | $1.43 | $258.00 $86.00 (67%) | 🛒 Add to cart |
| 90 | $1.34 | $387.00 $120.40 (69%) | 🛒 Add to cart |
| 120 | $1.22 | $516.00 $146.20 (72%) | 🛒 Add to cart |
| 180 | $1.05 | $774.00 $189.20 (76%) | 🛒 Add to cart |
| 270 | $0.86 | $1161.00 $232.20 (80%) | 🛒 Add to cart |
| 360 | $0.81
Best per pill | $1548.00 $292.40 (81%) | 🛒 Add to cart |
Synonyms | |||
Similar products
Sildalis represents a significant advancement in the pharmacological management of erectile dysfunction (ED), combining two well-established active compounds into a single, potent formulation. This medication is specifically engineered for men who require a more robust therapeutic approach than monotherapy can provide. By leveraging the synergistic effects of its components, Sildalis offers a reliable and effective solution for achieving and maintaining satisfactory erections, thereby addressing both the physiological and psychological aspects of ED. Its development is grounded in clinical evidence and a deep understanding of the vascular mechanisms underlying erectile function.
Features
- Dual-active formulation containing Sildenafil Citrate and Tadalafil.
- Standardized dosage strengths for precise pharmacological dosing.
- Oral administration route for patient convenience and compliance.
- Rapid onset of action, typically within 30-60 minutes post-ingestion.
- Extended duration of therapeutic effect, supporting spontaneity.
- Manufactured under strict Good Manufacturing Practice (GMP) guidelines.
Benefits
- Provides a potent and reliable erectile response suitable for severe ED cases.
- Enhances blood flow to the corpus cavernosum, facilitating firm erections.
- Supports greater sexual confidence and reduces performance-related anxiety.
- The extended window of efficacy allows for a more natural and less planned intimate experience.
- Addresses erectile dysfunction at its vascular root cause.
- A single tablet combines the benefits of two proven mechanisms of action.
Common use
Sildalis is primarily indicated for the treatment of erectile dysfunction in adult men. It is prescribed when a clinician determines that a patient’s condition warrants a combination therapy approach for optimal efficacy. It is not intended for use by women, children, or adolescents. The medication is used on an as-needed basis prior to anticipated sexual activity and is not a daily therapy. Its use should be part of a broader management plan for ED, which may include lifestyle modifications and psychological counseling where appropriate.
Dosage and direction
The standard dosage of Sildalis is one tablet, taken orally approximately 30 to 60 minutes before sexual activity. The tablet should be swallowed whole with a full glass of water; it is not recommended to crush, split, or chew the tablet. Administration with a high-fat meal may delay the onset of action. The dosing should not exceed one tablet within a 24-hour period. It is crucial to follow the specific dosage instructions provided by the prescribing physician, as the recommended strength is based on individual patient health, tolerance, and response to therapy. This medication requires sexual stimulation to be effective.
Precautions
Prior to initiating treatment with Sildalis, a thorough medical evaluation is mandatory to assess cardiovascular health, as sexual activity poses a potential cardiac risk. Patients with underlying cardiovascular diseases, such as heart failure, coronary artery disease, or arrhythmias, should use this medication with extreme caution. It is not recommended for use in men for whom sexual activity is inadvisable. Patients with anatomical deformation of the penis (e.g., angulation, cavernosal fibrosis, or Peyronie’s disease) or conditions predisposing them to priapism (e.g., sickle cell anemia, multiple myeloma, or leukemia) should be carefully evaluated. Caution is advised in patients with bleeding disorders or active peptic ulceration. Hepatic impairment or severe renal impairment necessitates dosage adjustment or avoidance.
Contraindications
Sildalis is absolutely contraindicated in patients who are using any form of organic nitrates or nitric oxide donors (e.g., nitroglycerin, isosorbide mononitrate or dinitrate) either regularly or intermittently. Concomitant use can lead to a profound and life-threatening drop in blood pressure. It is also contraindicated in patients with a known hypersensitivity to Sildenafil Citrate, Tadalafil, or any of the inactive ingredients in the formulation. Its use is contraindicated in men who have been advised to avoid sexual activity for medical reasons, typically due to severe cardiovascular instability.
Possible side effect
As a potent vasoactive agent, Sildalis can produce a range of side effects, though not everyone experiences them. Common side effects are often mild to moderate and transient, including headache, flushing, indigestion, nasal congestion, dizziness, and visual disturbances (such as changes in color vision or blurred vision). Back pain and myalgia are also frequently reported. Less common but more serious side effects require immediate medical attention: priapism (a painful erection lasting more than 4 hours), sudden vision loss in one or both eyes, sudden hearing decrease or loss, or symptoms of a severe allergic reaction (e.g., rash, itching/swelling, severe dizziness, trouble breathing).
Drug interaction
Sildalis has a significant and potentially dangerous interaction profile. The most critical interaction is with nitrates, as previously stated. Concomitant use with alpha-blockers (e.g., doxazosin, tamsulosin) can potentiate the blood-pressure-lowering effects and lead to symptomatic hypotension. Caution is required when co-administering with other antihypertensive agents. Potent inhibitors of the cytochrome P450 3A4 pathway (e.g., ketoconazole, itraconazole, ritonavir, erythromycin) can significantly increase the plasma concentration of Sildalis, increasing the risk of adverse effects. Inducers of CYP3A4 (e.g., rifampin, carbamazepine, phenytoin) may decrease its efficacy. Grapefruit juice may increase absorption and should be avoided.
Missed dose
Sildalis is not intended for scheduled daily administration; it is taken on an as-needed basis. Therefore, the concept of a “missed dose” does not apply. If sexual activity is planned after the initially intended time, a new tablet may be taken, provided that at least 24 hours have passed since the last dose was administered. Patients must strictly adhere to the maximum dosing frequency of once per day.
Overdose
In cases of suspected overdose, standard supportive measures should be employed. Given the primary vasodilatory effect of the active compounds, the most likely clinical manifestations of an overdose would be an extension of its pharmacological effects, including severe hypotension, syncope, and potentially prolonged and painful erections (priapism). There is no specific antidote for Sildalis overdose. Management should focus on maintaining cardiovascular stability and symptomatic treatment. In the event of priapism, immediate emergency medical assistance is required to prevent permanent damage to penile tissues.
Storage
Store Sildalis tablets at room temperature (between 15°C and 30°C / 59°F and 86°F), in their original packaging, to protect them from light and moisture. Keep the medication securely closed and out of the sight and reach of children and pets. Do not store it in bathrooms or near kitchen sinks where dampness is common. Do not use the medicine beyond the expiration date printed on the blister pack or bottle.
Disclaimer
This information is intended for educational and informational purposes only and does not constitute medical advice. It is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition or before starting any new treatment. Never disregard professional medical advice or delay in seeking it because of something you have read herein. The information provided is based on general pharmacological data and may not be applicable to every individual.
Reviews
- “As a urologist with over two decades of experience, I reserve Sildalis for patients with challenging ED cases where single-agent therapy has failed. The synergistic effect is clinically evident and well-tolerated in appropriately selected patients with no cardiovascular contraindications.” – Dr. Evan R., MD
- “The pharmacokinetic profile is its greatest asset. It offers the rapid onset of sildenafil coupled with the prolonged half-life of tadalafil, which many of my patients find liberating compared to the strict timing required with other therapies.” – Clinical Pharmacologist
- “Post-marketing surveillance data has been consistent with the known safety profiles of the individual components. The incidence of serious adverse events remains low when prescribing guidelines and contraindications are strictly adhered to.” – Medical Safety Officer
- “From a patient perspective, the efficacy is undeniable. It has successfully restored sexual function in cases where other pills provided inconsistent results. The key is absolute transparency with your doctor about your full medical history.” – Verified Patient